Propanc Biopharma, Inc. (PPCB)
OTCMKTS
· Delayed Price · Currency is USD
3.150
+0.440 (16.24%)
May 21, 2025, 3:45 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $28.91 million as of May 21, 2025. Its market cap has increased by 13,268.04% in one year.
Market Cap
28.91M
Enterprise Value
30.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.15
Market Cap Chart
Since February 14, 2022, Propanc Biopharma's market cap has increased from 1.26M to 28.91M, an increase of 2,199.30%. That is a compound annual growth rate of 161.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 20, 2025 | 28.91M | 17,336.58% |
Dec 31, 2024 | 165.82K | -50.41% |
Dec 29, 2023 | 334.41K | -33.52% |
Dec 30, 2022 | 502.99K | -60.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.63B |
Veradigm | 747.23M |
Nika Pharmaceuticals | 672.83M |
Tian'an Technology Group | 591.73M |
Elite Pharmaceuticals | 544.82M |
CytoDyn | 485.21M |
Glass House Brands | 477.46M |
Northwest Biotherapeutics | 416.49M |